High-density lipoproteins: an emerging target in the prevention of cardiovascular disease. (Q36611036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

High-density lipoproteins: an emerging target in the prevention of cardiovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Belinda A Cutri

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Neil J Hime

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

799-808

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17016470%20AND%20SRC:MED&resulttype=core&format=json

Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Cellular cholesterol flux studies: methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Tangier disease and ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

How high-density lipoprotein protects against the effects of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effects of lipids and lipoproteins on thrombosis and rheology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Formation of dysfunctional high-density lipoprotein by myeloperoxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effects of the amount and intensity of exercise on plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

The benefits of niacin in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Approach to lipoprotein management in 2001 National Cholesterol Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Apolipoprotein A-I mimetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, and Markedly Reduces Atherosclerosis in Apolipoprotein E–Null Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

Heart attacks: gone with the century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

F-actin modulates swelling-activated chloride current in cultured chick cardiac myocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

The antiatherogenic role of high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310097

7 January 2021